IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure

The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications

(2016) Katarzyna Zorena et al.   BIOMARKERS

Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium

(2016) Vasiliki V. Georgiopoulou et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mendelian Randomisation study of the influence of eGFR on coronary heart disease

(2016) Pimphen Charoen et al.   Scientific Reports

Innate Immunity and the Failing Heart

(2015) Douglas L. Mann   CIRCULATION RESEARCH

Interleukin 34: a new modulator of human and experimental inflammatory bowel disease

(2015) Stephanie Zwicker et al.   CLINICAL SCIENCE

IL-34 is a Treg-specific cytokine and mediates transplant tolerance

(2015) Séverine Bézie et al.   JOURNAL OF CLINICAL INVESTIGATION

IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease

(2015) Jea-Hyun Baek et al.   JOURNAL OF CLINICAL INVESTIGATION

The war against heart failure: the Lancet lecture

(2015) Eugene Braunwald   LANCET

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension

(2015) Agata Bielecka-Dabrowa et al.   Scientific Reports

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices

(2015) Cho-Kai Wu et al.   Scientific Reports

Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells

(2014) Yaming Wang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells

(2014) Laurence Preisser et al.   HEPATOLOGY

Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment

(2014) Aude I. Ségaliny et al.   INTERNATIONAL JOURNAL OF CANCER

IL-34 and CSF-1: similarities and differences

(2013) Yuko Nakamichi et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Increased Serum Interleukin-34 in Patients with Coronary Artery Disease

(2013) Zhenglong Li et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification

(2013) Antoni Bayes-Genis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes

(2013) F. Ciccia et al.   RHEUMATOLOGY

The role of the kidney in heart failure

(2012) M. Metra et al.   EUROPEAN HEART JOURNAL

Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community

(2012) Jennifer E. Ho et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients

(2011) M Chemel et al.   ANNALS OF THE RHEUMATIC DISEASES

Cystatin C: a step forward in assessing kidney function and cardiovascular risk

(2011) Johan Lassus et al.   HEART FAILURE REVIEWS

Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood

(2010) Hiroyuki Eda et al.   CYTOKINE

Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts

(2010) Hiroyuki Eda et al.   RHEUMATOLOGY INTERNATIONAL

Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome

(2008) H. Lin et al.   SCIENCE